Guanine’s upcoming tests will provide critical input data to create and train Machine Learning models Advancements in medical AI and precision medicine are constrained by antiquated IVD technologies that are not designed to provide rapid inexpensive quantities of low concentration biological materials in bodily samples. Guanine changes the paradigm to easily input test results with AI models for enhanced diagnoses. |
Neil Gordon B.Eng, MBA
President & CEO email LinkedIn Neil is a business executive specializing in managing advanced technology products and ventures. He was one of the one of first business consultants in nanotechnology. He headed commercialization for the NASA-led CANEUS and spun out a company from NASA’s Ames Research Center to commercialize NASA’s nanosensor. He co-developed a testing instrument for detecting RNA from bacteria and viruses. He subsequently invented and patented the oligonucleotide detection tag, the electronic sensing system, and AI diagnosis platform. |
Raj Bawa MD, PhD
VP and Chief IP Officer Raj is a MD PhD with background as a microbiologist and a pioneer in nanomedicine. He has been an active researcher for over three decades and has extensive hands-on bench experience, patent law track record and commercialization expertise. Raj is leading Guanine’s efforts to apply the technology to early stage sepsis diagnosis. |